Covered recipient · General Payments record
BECCA TRIEU LANDIS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2021–2024
$5,171.95
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $751.86 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $324.39 | 9 |
| Sight Sciences, Inc. | $117.67 | 1 |
| Dompe US, Inc. | $106.13 | 2 |
| Oyster Point Pharma, Inc. | $100.00 | 1 |
| Harrow Eye, LLC | $41.41 | 2 |
| ABBVIE INC. | $33.37 | 1 |
| Amgen Inc. | $28.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.37 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104134438 | CMS |
| Alcon Vision LLC | $110.02 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691967 | CMS |
| Alcon Vision LLC | $118.50 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691969 | CMS |
| Alcon Vision LLC | $3.41 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691955 | CMS |
| Alcon Vision LLC | $38.98 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691965 | CMS |
| Alcon Vision LLC | $13.50 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691959 | CMS |
| Alcon Vision LLC | $16.02 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691961 | CMS |
| Alcon Vision LLC | $16.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691963 | CMS |
| Alcon Vision LLC | $3.31 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691953 | CMS |
| Alcon Vision LLC | $3.81 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110691957 | CMS |
| Amgen Inc. | $28.89 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111628074 | CMS |
| Dompe US, Inc. | $13.23 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151398153 | CMS |
| Dompe US, Inc. | $92.90 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151398151 | CMS |
| Harrow Eye, LLC | $20.43 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145607458 | CMS |
| Harrow Eye, LLC | $20.98 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145607460 | CMS |
| Oyster Point Pharma, Inc. | $100.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147431867 | CMS |
| Sight Sciences, Inc. | $117.67 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151923632 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.